| Trial ID: | L0608 |
| Source ID: | NCT02581085
|
| Associated Drug: |
Tocotrienol
|
| Title: |
Tocotrienol Against the Progression of End Stage Liver Disease
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
End Stage Liver Disease;NASH - Nonalcoholic Steatohepatitis;NAFLD - Nonalcoholic Fatty Liver Disease
|
| Interventions: |
Drug: Tocotrienol (TCT);Other: Placebo
|
| Outcome Measures: |
Effect of Oral tocotrienols (TCT) on Model for End-Stage Liver Disease (MELD) score.nan
|
| Sponsor/Collaborators: |
Indiana University
|
| Gender: |
All
|
| Age: |
18 Yearsnan
|
| Phases: |
Phase 2
|
| Enrollment: |
70
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: Double (Participant, Care Provider).
|
| Start Date: |
26/06/2015
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2021
|
| Locations: |
United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02581085
|
